MainStreet Investment Advisors’s Exact Sciences EXAS Stock Holding History

MainStreet Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,023	Closed	-$930K	–	186
2020 Q4	$930K	Sell	7,023 -1,039	-13%	-$126K	0.07%	102
2020 Q3	$822K	Sell	8,062 -7,159	-47%	-$618K	0.06%	107
2020 Q2	$1.32M	Buy	15,221 +6,221	+69%	+$497K	0.09%	123
2020 Q1	$522K	Hold	9,000	–	–	0.06%	150
2019 Q4	$832K	Sell	9,000 -7	-0.1%	-$615	0.09%	105
2019 Q3	$813K	Buy	9,007 +7	+0.1%	+$798	0.11%	99
2019 Q2	$1.06M	Sell	9,000 -1,000	-10%	-$101K	0.14%	83
2019 Q1	$866K	Hold	10,000	–	–	0.12%	82
2018 Q4	$631K	Hold	10,000	–	–	0.1%	98
2018 Q3	$789K	Hold	10,000	–	–	0.11%	100
2018 Q2	$598K	Sell	10,000 -40	-0.4%	-$2.15K	0.09%	104
2018 Q1	$405K	Buy	10,040 +40	+0.4%	+$1.95K	0.06%	116
2017 Q4	$525K	Buy	+10,000	New	+$534K	0.08%	113

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MainStreet Investment Advisors's EXAS Position: Q1 2021 in Review

MainStreet Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 7,023 shares — an estimated $930K sold.

MainStreet Investment Advisors first reported a position in EXAS in Q4 2017 and held it in 13 quarters. The position peaked at $1.32M in Q2 2020. 646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

MainStreet Investment Advisors reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
MainStreet Investment Advisors sold 7,023 Exact Sciences shares in Q1 2021, an estimated $930K.
MainStreet Investment Advisors first reported a position in Exact Sciences in Q4 2017 and held it in 13 quarters.
MainStreet Investment Advisors's Exact Sciences position peaked at $1.32M in Q2 2020.
646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on MainStreet Investment Advisors's 13F filing for Q1 2021, filed 7 May 2021.